Compare Denison Mines Corp Ordinary Shares (Canada) (DNN) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Denison Mines Corp Ordinary Shares (Canada) vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Denison Mines Corp Ordinary Shares (Canada) trades at $2.43 (market cap $2.14B), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 5.9× Denison Mines Corp Ordinary Shares (Canada)'s market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Denison Mines Corp Ordinary Shares (Canada) nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Denison Mines Corp Ordinary Shares (Canada) for 1 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| DNN | HALO | |
|---|---|---|
Market Cap | $2.14B | $12.58B |
Volume | 56,727,592 | 2,179,278 |
Sector | Energy | Health |
52-Week High | $4.37 | $115.22 |
52-Week Low | $2.27 | $61.63 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $1.98B | $14.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Denison Mines Corp Ordinary Shares (Canada)
Denison Mines is a uranium mining, development, and exploration company focused on Canada's Athabasca Basin. Its portfolio includes the Wheeler River project and interests in other uranium projects and processing facilities.
Read more on DNN →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
